http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Choi Changil,Kang Minyong,Seo Seong Il,Suh Jungyo,Song Cheryn,Chung Jinsoo,Kim Sung Han,Park Jae Young,Hwang Eu Chang,Jeong Chang Wook,Kwak Cheol,Kim Jung Kwon,Hong Sung-Hoo 대한의학회 2024 Journal of Korean medical science Vol.39 No.3
Background: We sought to identify prognostic risk factors for one year recurrence in patient with renal cell carcinoma (RCC) after partial or radical nephrectomy. Methods: We performed a retrospective study of 1,269 patients with RCC after partial or radical nephrectomy and diagnosed recurrence using Korean Renal Cancer Study Group (KRoCS) database between January 1991 and March 2017. Recurrence-free survival (RFS), and overall survival (OS) were calculated using the Kaplan–Meier method and multivariate Cox regression analysis were performed to evaluate independent prognostic factors for recurrence Results: The median patient age was 56 years and median follow-up period was 67 months. Multivariable analysis demonstrated BMI greater than or equal to 23 and less than 30 (vs. BMI less than 23, hazard ratio [HR]: 0.707, P = 0.020) reduced recurrence one year postoperatively. Eastern Cooperative Oncology Group performance status (ECOG PS) greater than or equal to 1 (vs. ECOG PS 0, HR: 1.548, P = 0.007), high pathological T stage (pT2 vs. pT1, HR: 2.622, P < 0.001; pT3 vs. pT1, HR: 4.256, P < 0.001; pT4 vs. pT1, HR: 4.558, P < 0.001), and tumor necrosis (vs. no tumor necrosis, HR: 2.822, P < 0.001) were independent predictive factors for early recurrence within one year in patients with RCC. Statistically significant differences on RFS and OS were found among pathological T stages (pT2 vs. pT1; pT3 vs. pT1; pT4 vs. pT1, all P < 0.001). Conclusion: This large multicenter study demonstrated ECOG PS greater than or equal to 1, high pathological T stage, tumor necrosis and BMI less than 23 were significant prognostic risk factors of early recurrence within one year in patients with RCC who underwent nephrectomy.
High-Performance Li-Ion Battery Anodes Based on Silicon-Graphene Self-Assemblies
Kim, Nahyeon,Oh, Changil,Kim, Jaegyeong,Kim, Jeom-Soo,Jeong, Euh Duck,Bae, Jong-Seong,Hong, Tae Eun,Lee, Jung Kyoo The Electrochemical Society 2017 Journal of the Electrochemical Society Vol.164 No.1
<P>A series of Si/graphene sheet/carbon (Si/GS/C) composites was prepared by electrostatic self-assembly between amine-grafted silicon nanoparticles (SiNPs) and graphene oxide (GO). The Si/GS derived from carbonization of Si/GO assemblies showed limited cycling stability owing to loose cohesion between SiNPs and graphene, and increased impedances during cycling. To counteract the cycling instability of Si/GS, an additional carbon-gel coating was applied to the Si/GO assemblies in situ in solution followed by carbonization to yield dense three-dimensional particulate Si/GS/C composite with many internal voids. The obtained Si/GS/C composites showed much better electrochemical performances than the Si/GS owing to enhanced cohesion between the SiNPs and the carbon structures, which reduced the impedance buildup and protected the SiNPs from direct exposure to the electrolyte. A strategy for practical use of a high-capacity Si/GS/C composite was also demonstrated using a hybrid composite prepared by mixing it with commercial graphite. The hybrid composite electrode showed specific and volumetric capacities that were 200% and 12% larger, respectively, than those of graphite, excellent cycling stability, and CEs (>99.7%) exceeding those of graphite. Hence, electrostatic self-assembly of SiNPs and GO followed by in situ carbon coating can produce reliable, high-performance anodes for high-energy LIBs. (C) The Author(s) 2016. Published by ECS. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License (CC BY, http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse of the work in any medium, provided the original work is properly cited. All rights reserved.</P>
Jang, Young‐,Ho,Kim, June‐,Hong,Ban, Changill,Ahn, Kyohan,Cheong, Jae‐,Hun,Kim, Hyung‐,Hoi,Kim, Jung‐,Soo,Park, Yong‐,Hyun,Kim, Jun,Chun, Kook‐,Jin,Lee, Gyeon Blackwell Publishing Ltd 2012 CARDIOVASCULAR THERAPEUTICS Vol.30 No.5
<P><B>SUMMARY</B></P><P>Recent studies have shown that stromal cell derived factor‐1 (SDF‐1), first known as a cytokine involved in recruiting stem cells into injured organs, confers myocardial protection in myocardial infarction, which is not dependent on stem cell recruitment but related with modulation of ischemia‐reperfusion (I/R) injury. However, the effect of SDF has been studied only in a preischemic exposure model, which is not clinically relevant if SDF is to be used as a therapeutic agent. Our study was aimed at evaluating whether or not SDF‐1 confers cardioprotection during the reperfusion period. Hearts from SD rats were isolated and perfused with the Langendorff system. Proximal left coronary artery ligation, reperfusion, and SDF perfusion in KH buffer was done according to study protocol. Area of necrosis (AN) relative to area at risk (AR) was the primary endpoint of the study. Significant reduction of AN/AR by SDF in an almost dose‐dependent manner was noted during both the preischemic exposure and reperfusion periods. In particular, infusion of a high concentration of SDF (25 nM/L) resulted in a dramatic reduction of infarct size, which was greater than that achieved with ischemic pre‐ or postconditioning. SDF perfusion during reperfusion was associated with a similar significant reduction of infarct size as preischemic SDF exposure. Further studies are warranted to assess the potential of SDF as a therapeutic agent for reducing I/R injury in clinical practice.</P>
Chang, Chan Il,Yoo, Jae Wook,Hong, Sun Woo,Lee, Shi Eun,Kang, Hye Suk,Sun, Xiangao,Rogoff, Harry A,Ban, Changill,Kim, Soyoun,Li, Chiang J,Lee, Dong-ki Elsevier 2009 Molecular therapy Vol.17 No.4
<P>Small interfering RNAs (siRNAs) are short, double-stranded RNAs that mediate efficient gene silencing in a sequence-specific manner by utilizing the endogenous RNA interference (RNAi) pathway. The current standard synthetic siRNA structure harbors a 19-base-pair duplex region with 3' overhangs of 2 nucleotides (the so-called 19+2 form). However, the synthetic 19+2 siRNA structure exhibits several sequence-independent, nonspecific effects, which has posed challenges to the development of RNAi therapeutics and specific silencing of genes in research. In this study, we report on the identification of truncated siRNA backbone structures with duplex regions shorter than 19 bp (referred to as asymmetric shorter-duplex siRNAs or asiRNAs) that can efficiently trigger gene silencing in human cell lines. Importantly, this asiRNA structure significantly reduces nonspecific effects triggered by conventional 19+2 siRNA scaffold, such as sense-strand-mediated off-target gene silencing and saturation of the cellular RNAi machinery. Our results suggest that this asiRNA structure is an important alternative to conventional siRNAs for both functional genomics studies and therapeutic applications.</P>